Testing a new biopsy method for prostate cancer diagnosis
Part of Cancer, Kidney & urinary clinical trials.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 85 years old.
- You have never had a prostate biopsy before.
- You have a single suspicious spot on an MRI scan that is rated as medium or high risk (PI-RADS score of 3 or higher).
- You have a reason for a prostate biopsy, such as an abnormal digital rectal exam, suspicious finding on ultrasound or MRI, or a high PSA level.
- Your MRI and biopsy must be done within one month of each other.
- You have not had cancer treatments like radiation, chemotherapy, hormone therapy, or surgery before your MRI or biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a targeted biopsy to a standard sextant biopsy improves the detection of prostate cancer. It is for men aged 45 to 85 who have a suspicious spot on an MRI of their prostate and have not had a biopsy before.
This study aims to find the best way to take tissue samples (biopsies) from the prostate when MRI shows more than one suspicious spot. It will help doctors know exactly where to biopsy to reduce false negatives and avoid missing cancer.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This trial tests whether repeat MRI scans can help monitor suspicious prostate areas and avoid unnecessary biopsies. It aims to improve detection of significant prostate cancer while reducing invasive procedures.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.